| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928450 | American Heart Journal | 2014 | 11 Pages |
Abstract
Among patients with T2DM and stable angina, the therapeutic benefits of ranolazine were greater in those with higher HbA1c values. These data suggest that ranolazine is particularly beneficial in patients with stable angina who have suboptimally controlled T2DM.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Suzanne V. MD, MHA, Darren K. MD, MHSC, John A. MD, MPH, Yan PhD, Patrick MD, Ori MD, Luiz MD, Philip G. MS, Ann PhD, Bernard R. MD, Mikhail MD,